Halozyme Therapeutics (HALO) Stock Chart & Stock Price History $45.76 +0.95 (+2.12%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Halozyme Therapeutics Stock Price Performance 5 Day Performance+0.24%1 Month Performance-11.61%3 Month Performance-26.40%6 Month Performance+0.48%Year-To-Date Performance+23.81%1 Year Performance+17.70% Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide HALO Stock Chart for Thursday, November, 21, 2024 HALO Chart by TradingView Halozyme Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$44.81$45.76+2.12%$46.20$44.101.88 million shs$5.82 billion11/19/2024$42.57$44.81+5.26%$45.30$42.653.77 million shs$5.70 billion11/18/2024$45.65$42.57-6.75%$45.71$42.015.48 million shs$5.42 billion11/15/2024$53.96$45.65-15.40%$49.64$45.637.23 million shs$5.81 billion11/14/2024$58.61$53.96-7.93%$59.80$53.843.22 million shs$6.87 billion11/13/2024$59.61$58.61-1.68%$60.37$58.46830,640 shs$7.46 billion Get the Latest News and Ratings for HALO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$61.09$59.61-2.42%$62.02$59.241.51 million shs$7.58 billion11/11/2024$60.98$61.09+0.18%$62.13$60.551.47 million shs$7.77 billion11/08/2024$59.65$60.98+2.23%$61.19$59.141.11 million shs$7.76 billion11/07/2024$60.63$59.65-1.62%$60.95$58.761.06 million shs$7.59 billion11/06/2024$58.72$60.63+3.25%$61.30$58.011.53 million shs$7.68 billion11/05/2024$58.47$58.72+0.43%$58.74$57.091.14 million shs$7.44 billion11/04/2024$57.15$58.47+2.31%$59.39$56.822.12 million shs$7.41 billion11/01/2024$50.57$57.15+13.01%$57.62$52.563.40 million shs$7.24 billion10/31/2024$50.59$50.57-0.04%$51.21$50.011.88 million shs$6.44 billion10/30/2024$50.64$50.59-0.10%$51.08$50.03741,158 shs$6.44 billion10/29/2024$50.46$50.64+0.36%$50.96$50.11538,214 shs$6.45 billion10/28/2024$49.25$50.46+2.46%$50.78$49.711.17 million shs$6.42 billion10/25/2024$49.30$49.25-0.10%$49.84$48.85789,558 shs$6.27 billion10/24/2024$50.80$49.30-2.95%$50.79$49.121.04 million shs$6.27 billion10/23/2024$51.55$50.80-1.45%$51.69$50.51991,778 shs$6.47 billion10/22/2024$51.77$51.55-0.42%$52.03$51.151.11 million shs$6.56 billion10/21/2024$52.61$51.77-1.60%$52.77$51.451.10 million shs$6.59 billion Related Companies IOVA Stock Chart TWST Stock Chart RLAY Stock Chart ADPT Stock Chart ALLO Stock Chart KOD Stock Chart FATE Stock Chart BIIB Stock Chart UTHR Stock Chart INCY Stock Chart Receive HALO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Halozyme Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:HALO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump said you could learn something from this manEarly Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide vic...Wide Moat Research | SponsoredThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of ...WealthPress | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Halozyme Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Halozyme Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
